Showing results (81-90 of 116) with videos related to
Sort By:
Pageof 12
Annals of Epidemiology|September 27, 2005
Methodologic issues in follow-up studies of cancer incidence among occupational groups in the United StatesThomas J Bender, Colleen Beall, Hong Cheng, et al.BMC Musculoskeletal Disorders|April 2, 2014
Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiariesHuifeng Yun, Jeffrey R Curtis, Lingli Guo, et al.Arthritis and Rheumatism|February 14, 2012
Rates of malignancy associated with juvenile idiopathic arthritis and its treatmentTimothy Beukelman, Kevin Haynes, Jeffrey R Curtis, et al.Medical Care|March 23, 2011
Placebo adherence, clinical outcomes, and mortality in the women's health initiative randomized hormone therapy trialsJeffrey R Curtis, Joseph C Larson, Elizabeth Delzell, et al.Annals of the Rheumatic Diseases|May 19, 2011
The comparative risk of serious infections among rheumatoid arthritis patients starting or switching biological agentsJeffrey R Curtis, Fenglong Xie, Lang Chen, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 23, 2011
Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changesJie Zhang, Elizabeth Delzell, Hong Zhao, et al.Arthritis Care & Research|May 5, 2012
Physicians' explanations for apparent gaps in the quality of rheumatology care: results from the US Medicare Physician Quality Reporting SystemJeffrey R Curtis, Pradeep Sharma, Tarun Arora, et al.Arthritis Research & Therapy|September 22, 2011
Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritisJeffrey R Curtis, John W Baddley, Shuo Yang, et al.Arthritis Care & Research|September 10, 2014
Risks of herpes zoster in patients with rheumatoid arthritis according to biologic disease-modifying therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.Annals of the Rheumatic Diseases|March 11, 2014
Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapyHuifeng Yun, Fenglong Xie, Elizabeth Delzell, et al.Pageof 12